People on the move

Related tags Chief operating officer Management occupations Pharmacology

In-Pharmatechnologist's periodic round up of personnel moves in the
pharmaceutical sector includes a crop of new chief executives and
senior managers across the pharmachem, drug development and
manufacturing sectors.

Nat Ricciardi​ has been promoted to the post of president, Pfizer Global Manufacturing​, responsible for the drugmaker's production and worldwide distribution networks. He will succeed John Mitchell​ who will retire from the post at the end of this year.

Björn Ekström​ has become CEO of Olink Bioscience​, a Swedish company focusing on protein analysis technology that was founded in September. Previously, he was head of R&D at Pyrosequencing. He also held several positions within R&D at Amersham Biosciences and Pharmacia Biotech.

Australia's pSivida​ has appointed Mark Parry-Billings​ as R&D director of its UK-based drug delivery subsidiary pSiMedica. He joins the firm from Innovata Biomed.

PerkinElmer​ has promoted John Murphy​ to the new position of chief operating officer from his post as president of the company's optoelectronics business unit, and promoted Robert Friel​, chief financial officer since 1999, to executive vice president and added business development to his financial oversight duties

John McLaren​ has joined Akzo Nobel​ as director of corporate communications. He was previously employed by DSM, where he was responsible for the communication of the company's Vision 2005 strategy.

PowderMed​ of the UK, a company focusing on the development of therapeutic DNA vaccines based on the PowderJect needle-free injector, has appointed Adam Christie​ as chief business officer. He was formerly business development director of PPL Therapeutics and previously worked for GlaxoSmithKline, ABN Amro, Fisons, Abbott Laboratories and Schering.

Danish protein engineering company Borean Pharma​ has appointed Dr Johanna Holldack​ as CEO. She moves up from the post of chief operating officer, and was formerly at MediGene and Chiron.

Midwest BioResearch​, which provides outsourced drug disposition and toxicology services, has appointed Charles Jeuell​ as its vice president of analytical operations and Anna Koostra​ as a senior-level research scientist in the company's protein bioanalysis group.

Related topics Markets & Regulations

Related news

Show more

Follow us


View more